In 2024, Metrosert launched the Applied Research Center (RUK) as a structural unit to bridge the ‘valley of death’ in technology development – that critical phase where scientific findings often struggle to reach practical application. RUK operates in five high-potential fields: drone systems, autonomous vehicles, hydrogen technologies, biorefining, and health data analysis.
Janne Pullat (featured in the opening image), Head of Health Data at Metrosert, emphasized that the current focus is on reducing health data fragmentation and developing effective scientific and commercial use of this data. “The potential of health data is immense, but its accessibility and usage are still limited. Our goal is to create a platform for researchers, companies, and health tech developers that makes health data more accessible while maintaining strict security,” Pullat explained.
One of the primary focus areas is also the validation of AI-based health technologies and aligning them with both local and international regulatory requirements. “Conducting clinical trials is often too expensive and complex for startups. Our mission is to provide support in data analysis planning and obtaining compliance certificates, ensuring that innovative solutions can reach the market faster,” Pullat added.
From left to right: Pankaj Chejara, Health Data Scientist at Metrosert, Anders Eriksson, Lead Researcher in Health Data, and Janne Pullat, Head of Health Data
Metrosert is also working to create a regulatory roadmap to help companies and research institutions meet the requirements of the European Health Data Space (EHDS). The implementation of EHDS presents a significant opportunity for Estonia’s health tech sector. Additionally, new services are being developed to optimize data query processes and streamline the integration of health data from various sources.
According to Pullat, Metrosert’s goal is not to compete with universities or other research institutions but to provide them with practical support – from measurement standardization to accelerated data analysis. “Metrosert is the bridge that connects science and industry, making innovation applicable in everyday life. We have the expertise and technology to help scientific solutions reach the market,” she affirmed.
Metrosert joined the Tehnopol HealthTech community to seek collaboration partners and strengthen its impact in health data analysis and research development. “Tehnopol provides an excellent environment for developing new ideas and implementing them in the healthcare system. Our aim is to be a trusted partner for both research institutions and startups developing AI-based solutions,” Pullat said.
Metrosert’s vision for the future of its health data division is ambitious – the objective is to position Estonia as an international development hub where researchers and health tech developers can find a reliable platform for testing, validating, and bringing new solutions to market. “Our goal is to bring scientific data from the lab to the real world – quickly, securely, and in compliance with standards,” Pullat concluded.
Metrosert is a member of the Tehnopol HealthTech and campus community.
Discover more about Tehnopol:
Tehnopol Science and Business Park aims to support state-of-art technology entrepreneurship in Estonia and help it expand to the world. Our vision is to make the Estonian economy more sustainable by helping startups and SMEs to grow more quickly.
As the largest science park in the Baltics, Tehnopol provides enterprises with everything they need for growth, development, and real-life test environments.
